A Clinical Study on the Efficacy of the Yangxin Huoxue Formula in Treating Stable Angina Pectoris (Qi Deficiency and Blood Stasis Syndrome) with Concurrent Anxiety and Depression Disorders
Jia-Hao Weng,Feng-Gang Hou,Xue Wang,Zi-Yang Wang,Mei-Ping Wu
DOI: https://doi.org/10.2147/jmdh.s483104
2024-11-27
Journal of Multidisciplinary Healthcare
Abstract:Jia-Hao Weng, 1 Feng-Gang Hou, 2 Xue Wang, 1 Zi-Yang Wang, 1 Mei-Ping Wu 1, 3 1 Department of Cardiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, People's Republic of China; 2 Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, People's Republic of China; 3 School of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China Correspondence: Mei-Ping Wu, School of Integrated Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, No. 1200 of Cailun Road, Pudong District, Shanghai, 201203, People's Republic of China, Tel +86 136 6197 7245, Email Objective: This study evaluates the therapeutic effects of the Yangxin Huoxue Formula in the management of stable angina pectoris associated with Qi deficiency and blood stasis syndrome, co-occurring with anxiety and depressive disorders. The primary objective is to determine its efficacy in enhancing cardiac function and reducing emotional symptoms. Methods: A randomized, single-blind, placebo-controlled clinical trial was conducted with 94 individuals with stable angina pectoris. Participants were randomly allocated to either a treatment group receiving Yangxin Huoxue Formula granules or a placebo group receiving placebo granules, administered twice daily over a 12-week period. Primary outcome measures included assessments of cardiac function, angina frequency, PHQ-9 and GAD-7 scores, traditional Chinese medicine (TCM) syndrome improvements, and inflammatory markers. Results: The treatment group exhibited significantly greater improvements in cardiac output and reductions in peripheral vascular resistance compared to the placebo group. Additionally, a significant decrease in the frequency and duration of angina episodes was observed in the treatment group. Improvements in TCM syndrome scores and GAD-7 scores were also notably superior in the treatment group. No significant adverse reactions were recorded during the safety assessment of the treatment group. Conclusion: The Yangxin Huoxue Formula demonstrates efficacy in improving cardiac function, alleviating symptoms of anxiety and depression, reducing inflammatory mediator release, and enhancing quality of life in individuals with stable angina pectoris. The treatment was well-tolerated, confirming both its safety and therapeutic effectiveness. Keywords: Anxiety and depression disorders, qi deficiency and blood stasis, stable angina pectoris, traditional Chinese medicine treatment, Yangxin Huoxue Formula The increasing demands of society and the accelerated pace of modern life have positioned coronary artery disease (CAD) as a prominent threat to public health. According to the 2022 China Cardiovascular Health and Disease Report, CAD is responsible for 48% of deaths in rural regions and 45.86% in urban areas. A hospital-based meta-analysis reports that 51% of hospitalized patients with CAD in China exhibit symptoms of depression, with 0.5% to 25.44% experiencing severe depressive symptoms. 1 Studies have demonstrated that psychological disorders, particularly depression, increase the incidence and mortality rates of acute coronary syndrome. 2–6 Consequently, the field of "psychocardiology" has emerged, encouraging clinicians to integrate the assessment of psychological health into the care of individuals with CAD and to consider personalized treatment approaches. The pathogenesis of CAD in the presence of psychological disorders involves a complex interaction of multiple factors, including sympathetic nervous system overactivation, dysregulation of the hypothalamic-pituitary-adrenal axis, inflammatory responses, oxidative stress, vascular endothelial injury, abnormal platelet function, and behavioral factors. 7–13 Despite well-established diagnostic criteria for both CAD and related psychological conditions, therapeutic efficacy often remains inconsistent. This variability can be attributed to an incomplete understanding of the underlying disease mechanisms, reluctance among patients to use psychiatric medications, and the potential adverse effects of these treatments. 14 Consequently, the interplay between psychological states and cardiac symptoms is often insufficiently emphasized, impacting overall treatment outcomes. This study aims to evaluate the efficacy of a holistic treatment approach—specifically, the Yangxin Huoxue Formula—in managing stable angina pectoris, characterized by "Qi deficiency and -Abstract Truncated-
health care sciences & services